Novavax delays Covid vaccine emergency authorization submission to FDA until fourth quarter – CNBC

Novavax announced that it will delay the submission of its Covid-19 vaccine to the Food and Drug Administration for emergency use authorization until its fourth quarter.
Shares of the biotechnology … [+987 chars]